Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick A Cieslik

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Dalton Transactions (Cambridge, England : 2003)|February 10, 2025
Bispidine coordination chemistryKatharina Bleher, Patrick A Cieslik, Peter Comba
Journal of Medicinal Chemistry|November 21, 2025
α Emitter-Labeled Radiopeptides for Targeted α Therapy of TumorsPatrick A Cieslik, Björn Wängler, Carmen Wängler
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 8, 2023
Radiolabelled <sup>177</sup> Lu-Bispidine-Trastuzumab for Targeting Human Epidermal Growth Factor Receptor 2 Positive CancersPatrick A Cieslik, Simon Klingler, Mirja Nolff, et al.
JACS Au|June 27, 2025
Light-Induced Synthesis and Radiotheranostic Treatment of Gastric Cancer with <sup>161</sup>Tb-Labeled Monoclonal AntibodiesPatrick A Cieslik, Dominik Roth, Eda Nisli, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Dalton Transactions (Cambridge, England : 2003)|February 10, 2025
Bispidine coordination chemistryKatharina Bleher, Patrick A Cieslik, Peter Comba
Journal of Medicinal Chemistry|November 21, 2025
α Emitter-Labeled Radiopeptides for Targeted α Therapy of TumorsPatrick A Cieslik, Björn Wängler, Carmen Wängler
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 8, 2023
Radiolabelled <sup>177</sup> Lu-Bispidine-Trastuzumab for Targeting Human Epidermal Growth Factor Receptor 2 Positive CancersPatrick A Cieslik, Simon Klingler, Mirja Nolff, et al.
JACS Au|June 27, 2025
Light-Induced Synthesis and Radiotheranostic Treatment of Gastric Cancer with <sup>161</sup>Tb-Labeled Monoclonal AntibodiesPatrick A Cieslik, Dominik Roth, Eda Nisli, et al.
Pageof 1